PMID- 10595557 OWN - NLM STAT- MEDLINE DCOM- 20000107 LR - 20181113 IS - 0961-8368 (Print) IS - 1469-896X (Electronic) IS - 0961-8368 (Linking) VI - 8 IP - 11 DP - 1999 Nov TI - A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding. PG - 2513-8 AB - The recombinant human nerve growth factor (hNGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin 4/5 (NT4/5), and murine NGF (mNGF) dimers all undergo rapid unfolding and dissociation to monomer in GdnHCl. Fluorescence spectroscopy, reversed-phase high-performance liquid chromatography, and size-exclusion chromatography were used to show that this monomer M1 converts slowly to a more fully unfolded monomer, M2, by a first order process with half-lives of 22, 2.5, 1.6, and 0.73 h for hNGF, mNGF, NT-3, and BDNF, respectively, at 25 degrees C. Linear Arrhenius plots for the conversion of M1 to M2 yielded activation energies of 27, 22, 24, and 24 kcal/mol for hNGF, mNGF, NT-3, and BDNF, respectively. The refolding of these neurotrophins from 5 M GdnHCl was also first order with NT-3 the slowest to refold and BDNF the fastest. Threading of the N-terminus out through the cystine-knot loop present in each of these proteins is proposed as the slow step in unfolding. The number of amino acids in the cystine-knot loop (14 for hNGF, mNGF, NT-3, and BDNF; 21 for NT4/5), and the number and position of the proline residues in this loop (2 for hNGF; 1 for mNGF, NT-3, BDNF, and NT4/5) correlate with the relative rates of unfolding. The smaller the loop and the greater the number of prolines, the more hindered and slower the unfolding. FAU - De Young, L R AU - De Young LR AD - Department of Pharmaceutical Research and Development, Genentech, Inc., South San Francisco, California 94080, USA. Ldeyoung@angiogenix.com FAU - Schmelzer, C H AU - Schmelzer CH FAU - Burton, L E AU - Burton LE LA - eng PT - Journal Article PL - United States TA - Protein Sci JT - Protein science : a publication of the Protein Society JID - 9211750 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Macromolecular Substances) RN - 0 (Nerve Growth Factors) RN - 0 (Neurotrophin 3) RN - 0 (Recombinant Proteins) RN - JU58VJ6Y3B (Guanidine) SB - IM MH - Amino Acid Sequence MH - Animals MH - Brain-Derived Neurotrophic Factor/*chemistry/metabolism MH - Chromatography, Gel MH - Chromatography, High Pressure Liquid MH - Guanidine MH - Humans MH - Kinetics MH - Macromolecular Substances MH - Mice MH - Models, Molecular MH - Molecular Sequence Data MH - Nerve Growth Factors/*chemistry/metabolism MH - Neurotrophin 3/*chemistry/metabolism MH - Protein Conformation MH - *Protein Denaturation MH - Recombinant Proteins/chemistry/metabolism MH - Sequence Alignment MH - Sequence Homology, Amino Acid MH - Thermodynamics PMC - PMC2144210 EDAT- 1999/12/14 00:00 MHDA- 1999/12/14 00:01 PMCR- 2000/05/01 CRDT- 1999/12/14 00:00 PHST- 1999/12/14 00:00 [pubmed] PHST- 1999/12/14 00:01 [medline] PHST- 1999/12/14 00:00 [entrez] PHST- 2000/05/01 00:00 [pmc-release] AID - 10.1110/ps.8.11.2513 [doi] PST - ppublish SO - Protein Sci. 1999 Nov;8(11):2513-8. doi: 10.1110/ps.8.11.2513.